Mobius Therapeutics LLC — Form D
Mobius Therapeutics LLC of St. Louis, MO, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-25. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-10-25
- Form: D
- Accession: 0001407296-13-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Minimum investment: $25K
- Investors: 19
- Date of first sale: 2013-10-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-205277
Issuer
- Name: Mobius Therapeutics LLC
- CIK: 0001407296
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 4041 FOREST PARK AVENUE, St. Louis, MO, 63108
- Phone: 314-615-6930
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Edward J Timm | Director | St. Louis, MO |
| Dean J Vandekamp | Director | St. Louis, MO |
| Mark J Wright | Director | Darien, CT |
| James J Anderson | Executive Officer | St. Louis, MO |
| Edward J Timm | Executive Officer | St. Louis, MO |
| Mark J Wright | Executive Officer | Darien, CT |
| Mark Wright | Executive Officer | Rochester, NY |
| Ed Timm | Director | St. Louis, MO |
| Ed Timm | Executive Officer | St. Louis, MO |
Other filings by this issuer (2)
More